Developing regions vs Ecuador: Proportion of the target population who received the final dose of
Developing regions
26.0%
in 2024
Ecuador
89.0%
in 2024
Developing regions rank
10th
Ecuador rank
10th
Proportion of the target population who received the final dose of over time
- Developing regions
- Ecuador
How they compare
Ecuador currently reports 89.0% against 26.0% in Developing regions, a difference of 63.0%.
That makes Ecuador's figure about 3.4 times Developing regions's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was Ecuador ahead.
Developing regions ranks 10th and Ecuador ranks 10th of 13 groups.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.8% | 81.2% | 73.3% | Ecuador |
| 2020s | 14.0% | 45.8% | 31.8% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Developing regions or Ecuador?
- Ecuador, at 89.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Developing regions and Ecuador?
- 63.0%, with Ecuador ahead.
- How many years of comparable data are there for Developing regions and Ecuador?
- 11 years are reported by both, from 2014 to 2024.
- How do Developing regions and Ecuador rank globally for proportion of the target population who received the final dose of?
- Developing regions ranks 10th and Ecuador ranks 10th of 13 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.